Osservatorio europeo delle droghe e delle tossicodipendenze
Relazione annuale 2004:
evoluzione del fenomeno della droga nell’Unione europea ed in Norvegia
Abdulrahim, D. (2001), Substance misuse and mental health co-morbidity (dual diagnosis). Standards for mental health services, The Health Advisory Service, Londra.
Andreasen, J. (2002), «Ansvaret for de psykotivke stofmisbrugere skal vara psykiatriens», Ugeskrift for læger, n. 51.
AST/RELIS (2002), Punto focale OEDT Lussemburgo, Direction de la Santé, Réseau National d’Information sur les Drogues et les Toxicomanies, RELIS, Rapport National, PFN, Lussemburgo.
Bakken, K., Landheim, S., Vaglum, P. (2003), «Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?», Alcohol and Alcoholism, n. 38, pagg. 54–59.
Barrowclough, C., Haddock, G., Tarrier, N., et al. (2001), «Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with co-morbidity schizophrenia», American Journal of Psychiatry, n. 158, pagg. 1706–1713.
Baudis, R. (2004), «A drug court type project for juvenile drug-related offenders in Germany», Substance Abuse, Drug Courts and Mental Health Treatment Services, Atti di conferenza, Servizi Area Penale Carceri, Milano, 5–7 febbraio 2004.
Beck, F. (2003), Dépistage de l’usage problématique de cannabis: échelle et référence (progetto di relazione), ESCAPAD, OFDT, Parigi.
Beck, F. and Legleye, S. (2003), Drogues et adolescence: usages de drogues et contextes d’usage entre 17 et 19 ans – évolutions récentes, ESCAPAD 2002, Parigi: OFDT.
Benschop, A., Rabes, M., Korf, D. (2002), Pill testing – ecstasy and prevention. A scientific evaluation in three European cities, Rozenberg Publishers, Amsterdam.
Berglund, M., et al. (ed.) (2003), Treating alcohol and drug abuse. An evidence-based review, Wiley, Londra.
Berthel, T. (2003), «Psychiatrische Komorbidität», in: Beubler, E., Haltmayer, H., Springer, A., Opiatabhängigkeit. Interdisciplinäre Aspekte für die Praxis, Springer, Vienna.
Best, D., Lan-Ho, M., Zador, D., et al. (2000), «Overdosing on opiates. Thematic review. Part I – causes», Drug and Alcohol Findings, n. 4, pagg. 4–20.
Best, D., Lan-Ho, M., Zador, D., et al. (2001), «Overdosing on opiates. Thematic review. Part II – prevention», Drug and Alcohol Findings, n. 5, pagg. 4–18.
Beutel, M. (1999), «Sucht und sexueller Missbrauch», Psychotherapeut, n. 44, pagg. 313–319.
Bird, S., Rotily, M. (2002), «Inside methodologies for counting blood-borne viruses and injector-inmates’ behavioural risks – results from European prisons», Howard Journal, n. 41 (2).
Bovenkerk, F. and Hogewind, W. I. M. (2002), Hennepteelt in Nederland: het probleem van criminaliteit en haar bestrijding. Utrecht: Willem Pompe Instituut voor Strafrechtswetenschappen.
Bronisch, T., Wittchen, H.-U. (1998), «Komorbidität von suizidalem Verhalten, Sucht, Depression und Angststörungen», Suizidprophylaxe, n.1, pagg. 22–26.
Chinman, M., Imm, P., Wandersmann, A. (2004), Getting to outcomes 2004. Promoting accountability through methods and tools for planning, implementation, and evaluation, RAND Corporation, Santa Monica.
CND (2004), World drug situation with regard to drug trafficking: report to the Secretariat, Consiglio economico e sociale, Nazioni Unite, Vienna.
Commonwealth Department for Health and Ageing (2003), National Co-morbidity Project. Current practice in the management of clients with co-morbidity mental disorders and substance use disorders in tertiary care settings, Commonwealth of Australia, Canberra.
Crawford, V. (2001), Co-existing problems of mental health and substance misuse (‘dual diagnosis’): a review of relevant literature, Royal College of Psychiatrists, Londra.
Currie, C., Roberts, C., Morgan, A., et al. (2004), Young people's health in context. Health Behaviour in School-aged Children (HBSC) study: international report from the 2001/2002 survey, Health Policy for Children and Adolescents, n.4, Ginevra, WHO/OMS Europa.
Deehan, A., Saville, E. (2003), Calculating the risk: recreational drug use among clubbers in the South East of England, Home Office, Relazione on line, n. 43/2003.
Department of Health (2002a), Mental health policy implementation guide: dual diagnosis good practice guide, Department of Health, Londra.
Department of Health (2002b), Models of care for substance misuse treatment: promoting quality, efficiency and effectiveness in drug misuse treatment services. Full report for consultation, Department of Health, Londra.
Dialog (2000), Jahresbericht 1999, Verein Dialog – Hilfs- und Beratungsstelle für Suchtgiftgefährdete und deren Angehörige, Vienna.
Dolan, K. (1997–98), «Evidence about HIV transmission in prisons», Canadian HIV-AIDS Policy and Law Newsletter, n. 3-4, pagg. 32–38.
Dolan, K., Rutter, S., Wodak, A. D. (2003), «Prison-based syringe exchange programmes: a review of international research and development», Addiction, n. 98, pagg. 153–158.
Drake, R., Mercer-McFadden, C., Mueser, K., et al. (1998), «Review of integrated mental health and substance abuse treatment for patients with dual disorders», Schizophrenia Bulletin, n. 24, pagg. 589–608.
DrugScope (2004), Druglink, n. 19 (1), gennaio/febbraio 2004.
Dusenbury, L., Falco, M. (1995), «Eleven components of effective drug abuse prevention curricula», Journal of School Health, n, 65, pagg. 420–425.
Eland, A., Van de Glint, G. (2001), Diagnostiek en behandeling van ADHD binnen de intramurale verslavingszorg, Trimbos Instituut, Utrecht.
OEDT (2001), Cocaina e cocaina crack (questione specifica), in Annual report 2001: the state of the drugs problem in the acceding and candidate countries to the European Union (Relazione annuale 2001: stato del problema della droga nei paesi in via di adesione all’Unione europea), Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
OEDT (2003a), Annual report 2003: the state of the drugs problem in the acceding and candidate countries to the European Union, Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
OEDT (2003b), Relazione annuale 2003: evoluzione del fenomeno della droga nell'Unione europea e in Norvegia, Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
OEDT (2003c), Focus sulle droghe n. 11, Epatite C: un’epidemia latente, Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
OEDT (2003d), The international profile of cannabis clients, expert meeting on treatment demand – meeting with International organisations, Lisbona, 24 giugno 2003.
OEDT (2004a) European report on drug consumption rooms, Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
OEDT (2004b), Focus sulle droghe n. 13, Deaths, Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
OEDT (2004c), An overview of cannabis potency in Europe, EMCDDA Insights 6. Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
OEDT (2004d), Hepatitis C and injecting drug use: impact, costs and policy options. EMCDDA Monographs 7. Osservatorio europeo delle droghe e delle tossicodipendenze, Lisbona.
Emmanuelli, J. (2003), «Siamois: Tendances en matière de réduction des risques chez les usagers de drogues par voie iv», in: Bello, J.-Y., Toufik, A., Gandilhon, M., et al., Phénomènes émergents liés aux drogues en 2002, quatrième rapport national du dispositif TREND, pagg. 263–267, OFDT, Parigi.
Estebanez, P., Russell, N. K., Aguilar, M.D., et al. (2001), «Determinants of HIV prevalence amongst female IDU in Madrid», European Journal of Epidemiology, n. 17, pagg. 573–580.
European Centre for the Epidemiological Monitoring of AIDS (EuroHIV) (2004), HIV/AIDS Surveillance in Europe, End-year report, 2003, n. 70. Saint-Maurice: Institut de Veille Sanitaire.
Commissione europea (1999), Evaluating socio-economic programmes: glossary of 300 concepts and technical terms, Lussemburgo, Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Commissione europea (2003), Evaluating EU activities – a practical guide for Commission Services, Lussemburgo, Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Europol (2002), Serious crime overviews: counter money laundering, a European Union perspective, Europol, L’Aia.
Europol (2003), Relazione UE sulla criminalità organizzata, Europol, L’Aia.
Facy, F. (1999), Toxicomanes et prescription de méthadone, EDK, Parigi.
Farrell, M. (2002), Final Evaluation of the Pilot Drug Court, Courts Service, Dublino.
FATF (2003a), Annual report 2002–2003.
FATF (2003b), Combating the abuse of alternative remittance systems: international best practices, FATF, Parigi.
Flay, B. (2000), «Approaches to substance use prevention utilizing school curriculum plus social environment change», Addictive Behaviours, n. 25, pagg. 861–866.
Fridell, M. (1991), Personlighet och drogmissbruk. En forskningsöversikt, PM-serie, n. 10, Centralförbundet för alkohol- och narkotikaupplysnings (CAN), Stoccolma.
Fridell, M. (1996), Psykisk störning och narkotikamissbruk. Socialstyrelsen. Psykiskt störda missbrukare, SoS-rapport 1996, n. 14, Socialstyrelsen, Stoccolma.
Gerdner, A. (2004), Utfall av LVM-vård: översikt och syntes av hittilsvarande studier, Bilaga 4 till LVM-utredningen, SOU 2004: 3 Tvång och förändring – Rättssäkerhet, vårdens innehåll och eftervård, Socialdepartementet, Stoccolma.
GFATM, Segretariato (2004), The Global Fund Grant status report.
Giuliani, M., Suligoi, B (2004), «Italian STI Surveillance Working Group. Differences between nonnational and indigenous patients with sexually transmitted infections in Italy and insight into the control of sexually transmitted infections», Sexually Transmitted Diseases, n. 31 (2), pagg. 79–84.
Gore, S.M. (1999), «Fatal uncertainty: death-rate from use of ecstasy or heroin», Lancet, n. 354, pagg. 1265–1266.
Hall, W., Degenhardt,L., Lynskey, M (2001), The health and psychological effects of cannabis use, serie monografica, n. 44, 2^ ed., Commonwealth of Australia, Canberra.
Hannon F., Keleher C., e Friel, S. (2000), General healthcare study of the Irish prison population, Stationery Office, Dublino.
Hansen, W. (1992), «School-based substance abuse prevention: a review of the state of the art in curriculum, 1980–1990», Health Education Research, n. 7, pagg. 403–430.
Hibell, B., Andersson, B., Ahlstrom, S., et al., (2000), Relazione 1999 ESPAD: The European School Survey Project on Alcohol and Other Drugs. Consiglio svedese per l’informazione su alcool e altre droghe (CAN) e Consiglio d’Europa, Gruppo Pompidou.
Hope, V., Ncube, F., de Souza, L., et al. (2004), Shooting up: infections in injecting drug users in the United Kingdom, 2002, Eurosurveillance Weekly, n. 8 (4), 22 gennaio 2004.
INCB (2004a), Report of the International Narcotics Control Board 2003, Nazioni Unite, INCB, New York.
INCB (2004b), Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, Nazioni Unite, INCB, New York.
Interpol (2002), Activities report, Interpol, Lione.
Jansson, I., Fridell, M. (2003), Psykisk och somatisk belastning hos tvångsvårdade kvinnor, LVM och LVU-vårdade kvinnor vid Lunden, SiS-rapport n. 1/03, Statens Institutionsstyrelse, Stoccolma.
Joint Meeting of the Faculty of Substance Misuse of the Royal College of Psychiatrists and the World Psychiatric Association (2003), Innovations in the treatment of addiction, Barcellona, 1–2 maggio 2003.
Jonsson, S. (2001) «Långstorps vård- och behandllingshem – En ufallsstudie», Psykologexamensuppsats, vol. III:20, Institutionen för psykologi, Lund.
Kessler, R.C., Aguilar-Gaxiola S., Andrade L., et al. (2001), «Mental-substance comorbidities in the ICPE surveys», Psychiatrica Fennica, n. 32, pagg. 62–79.
Kokkevi, A., Facy, F. (1995), «Personality traits and psychopathology in drug addiction», European Addiction Research, n. 1, pagg. 194–198.
Kokkevi, A., Stefanis, C. (1995), «Drug abuse and psychiatric comorbidity», Comprehensive Psychiatry, n. 36, pagg. 329–337.
Kraus, L., Augustin, R., Korf, D., et al. (2003), Cannabis use in France, Germany, Greece and Spain: has age of first use experience shifted towards younger age? (relazione).
Krausz, M. (1996), «Old problems – new perspectives», European Addiction Research, n. 2, pagg. 1–2.
Krausz, M. (1999), «Editorial. Addiction and mental health», European Addiction Research, n. 5, pagg. 53–54.
Krausz, M. (1999), «Komorbidität – Psychische Störungen bei Schwerstabhängigen; Forschungsstand und klinische Konsequenzen», in: Bellebaum, C. Jellinek, Westermann, B., Mehr als Abhängig? Versuche mit Methadon und Heroin, pagg. 100–114, Deutscher Studienverlag, Weinheim.
Krausz, M., Verthein, U., Degkwitz, P. (1999), «Psychiatric co-morbidity in opiate addicts», European Addiction Research, n. 5, pagg. 55–62.
Landheim, A. S., Bakken, K., Vaglum, P. (2003), «Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics», European Addiction Research 9, pagg. 8–17.
Lauritzen, G, Waal, H, Amundsen, A., Arner, O. (1997), «A nationwide study of Norwegian drug abusers in treatment: methods and findings», Nordisk alkohol- & narkotikatidsskrift 14, pagg. 43–63.
Ley, A., Jeffery, D.P., McLaren, S., Siegfried, N. (2003), «Psychosocial treatment programmes for people with both severe mental illness and substance misuse», Cochrane Review, The Cochrane Library, vol. 4, Wiley, Chichester, Regno Unito.
Liappas, J. (2001), «Drug addiction: a multidimensional therapeutic problem», Itaca, n. 6, pagg. 9–22.
Lima, A.R., Lima, M.S., Soares, B.G.O., Farrell, M. (2004a), Carbamazepine for cocaine dependence, Cochrane Review, The Cochrane Library, vol. 2, 2004.
Lima, M.S., Reisser, A.A.P., Soares, B.G.O., Farrell, M. (2004b), Antidepressants for cocaine dependence, Cochrane Review, The Cochrane Library, vol. 2, 2004.
Long, J., Allwright, S., Begley, C. (2004), Prisoners’ views of injecting drug use and harm reduction in Irish prisons, International Journal of Drug Policy, in stampa.
Marsden, J., Gossop, M., Stewart, D., et al. (2000), Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment outcome study. British Journal of Psychiatry 176, pagg. 285–289.
McIntosh, C., Ritson, B (2001), «Treating depression complicated by substance misuse», Advances in Psychiatric Treatment, n. 7, pagg. 357–364.
McVeigh, J., Beynon, C., Bellis, M. A. (2003), New challenges for agency based exchange schemes: analysis of 11 years of data (1991–2001) in Merseyside and Cheshire, United Kingdom, International Journal of Drug Policy, n. 14, pagg. 399–405.
Mears, A., Clancy, C., Banerjee, S., et al. (2001), Co-existing problems of mental disorder and substance misuse (dual diagnosis): a training needs analysis, Royal College of Psychiatrists, Londra.
Migliori, G.B., Centis, R. (2002), «Problems to control TB in eastern Europe and consequences in low incidence countries», Monaldi Archive of Chest Diseases, n. 57, pagg. 285–290.
Morel, A. (1999), «Troubles psychiatriques associés à la toxicomanie», Interventions, n. 72, pagg. 35–40.
Moyle, P. (2003), International drug court developments, models and effectiveness, Progetto di tribunali dedicati alla droga, Gruppo Pompidou, Strasburgo.
Murphy-Lawless, J. (2002), Fighting back: women and the impact of drug abuse on families and communities, Liffey Press, Dublino.
Murray, R., Grech, A., Phillips, P., Johnson, S. (2003), «What is the relationship between substance abuse and schizophrenia?», in: Murray, R., Jones, P., Susser, E., et al., The epidemiology of schizophrenia, Cambridge University Press, Cambridge.
Neale, J. e Robertson, M. (2004), «Recent cocaine and crack use among new drug treatment clients in Scotland», Drugs: Education, Prevention and Policy, n. 11(1), pagg. 79–90.
Nestler, E. J. (2001), Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience 2(2), pagg.119–128.
Öjehagen, A., Schaar, I. (2003) «Mentally ill substance abusers in Svezia: a 5-year follow-up of a multisite study of co-operation between psychiatric services and social authorities», in: Carrà, G., Clerici, M. , Dual diagnosis: filling the gap, John Libbey Eurotext, Parigi.
Olin, N., Plasait, B. (2003), Drogue: l’autre cancer. Rapport de la Commission d’enquête sur la politique nationale de lutte contre les drogues illicites, Sénat, Parigi.
Origer, A., Delucci, H. (2002), Etude épidemiologique et méthodologique des cas de décès liés à l’usage illicite des substances psycho-actives. Analyse comparative (1999–2000), Serie di ricerche n. 3, Punto focale OEDT Lussemburgo-CPR Santé, Lussemburgo.
Paglia, A., Room, R. (1999), Preventing substance use problems among youth: a literature review and recommendations, Journal of Primary Prevention, vol. 20 (1), pagg. 3–50.
Pani, P. P., Trogu, E., Carboni, G., et al. (2003), «Psychiatric severity and treatment response in methadone maintenance treatment programmes: new evidence», Heroin Addiction & Related Clinical Problems, n. 5, pagg. 23–36.
Pedersen, M.U. (2001), Substitutionsbehandling. Organiseringer, stofmisbrugere, effekter, metoder. Del 1, Center for Rusmiddelforskning, Aarhus Universitet, Århus.
Popov, P. (2003), «Alkohol», in: Kalina, K. a spol. (ed.) Drogy a drogové závislosti – mezioborový přístup, Kapitola 3/1, Úřad vlády ČR – NMC, Praga
Ravelli, A., Bijl, R. V., Van Zessen, G. (1998), «Comorbiditeit van psychiatrische stoornissen in de Nederlandse bevolking; resultaten van de Netherlands Mental Health Survey and Incidence Study (NEMESIS)», Tijdschrift voor Psychiatrie, n. 40, pagg. 531–544.
Relazioni nazionali Reitox (2003).
Rhodes, T., Lilly, R., Fernández, C., et al. (2003), «Risk factors associated with drug use: the importance of ‘risk environment’», Drugs: Education, Prevention and Policy, n. 10, pagg. 303–329.
Roeg, D. P. K., van de Goor, L. A. M. and Garretsen, H. F. L. (2004) When a push is not a shove: assertive care, Dutch-style. Drugs and Alcohol Today , Vol 4 (in stampa).
Rooney, S., Kelly, G., Bamford, L., et al. (1999), «Co-abuse of opiates and benzodiazepines», Irish Journal of Medical Science, n. 168, pagg. 36–41.
SAMHSA, Ufficio studi applicati (2001), Trends in initiation of substance use, 2001, Indagine nazionale sulll’abuso di droghe tra i nuclei familiari.
SAMHSA, Ufficio studi applicati (2002), Results from the 2002 National Survey on Drug Use and Health. National findings.
Schifano, F., Oyefeso, A., Corkery, J., et al. (2003), «Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002», Human Psychopharmacology and Clinical Exposure, n. 18, pagg. 519–524.
Seivewright, N., Donmall, D., Douglas, J., et al. (2000), «Cocaine misuse treatment in England», International Journal of Drug Policy, n. 11, pagg. 203–15.
Siliquini, R., Zeppegno, P., Faggiano, F. (2002), «Patologia psichiatrica e consumo di sostanze: descrizione preliminare dei casi di uno studio caso–controllo», in: Faggiano, F., OED Piemonte – Rapporto 2002, Osservatorio Epidemiologico Dipendenze, Torino.
Sosial- og helsedepartementet (1999), Rapportane I, II, III, frå Arbeidsgruppa for å gjennomgå hjelpe- og behandlingstilbodet for rusmiddelmisbrukarar.
Springer, A. (2003a), Different types of medically assisted treatment, Conferenza dedicata al monitoraggio dei trattamenti, OEDT, Lisbona.
Springer, A. (2003b), «Psychotherapeutische Aspekte», in: Beubler, E., Haltmayer, H., Springer, A., Opiatabhängigkeit. Interdisziplinäre Aspekte für die Praxis, Springer, Vienna.
Stothard, B., Ashton, M. (2000), «Education’s uncertain saviour», Drug and Alcohol Findings, n. 3, pagg. 4–7, 16–20.
Stöver, H. (2001), Bestandsaufnahme ‘Crack Konsum’ in Deutschland: Verbreitung, Konsummuster, Risiken und Hilfeangebote, Relazione finale, Istituto per la ricerca sulle droghe (BISDRO), Università di Brema, Brema.
Stöver, H. e Nelles, J. (2003), «Ten years of experience with needle and syringe exchange programmes in European prisons», International Journal of Drug Policy, n. 14, pagg. 437–444.
Ter Bogt, T., Engels, R.C.M.E. (2004), «Party style: notice for and effects of MDMA at Rave parties», Substance Use and Misuse (in stampa).
Tobler, N. (2001), «Prevention is a two-way process», Drug and Alcohol Findings, n. 5, pagg. 25–27.
Tobler, N., Stratton H.H. (1997), «Effectiveness of school-based drug prevention programs: a meta-analysis of the research», Journal of Primary Prevention, n. 18 (1), pagg. 71–128.
Tobler, N. S., Roona, M. R., Ochshorn, P. (2000), «School-based adolescent prevention programs: 1998 meta-analysis», Journal of Primary Prevention, n. 20, pagg. 275–336.
Uchtenhagen, U., Zeiglgänsberger, W (2000), Suchtmedizin – Konzepte, Strategien und therapeutisches Management, Urban & Fischer Verlag, Monaco di Baviera.
UNODC (2003a), Global illicit drug trends 2003, Ufficio delle Nazioni Unite contro la droga e il crimine, Vienna.
UNODC (2003b), Ecstasy and amphetamines: global survey 2003, Ufficio delle Nazioni Unite contro la droga e il crimine, Vienna.
UNODC e governo del Marocco (2003), Morocco cannabis survey 2003, Ufficio delle Nazioni Unite contro la droga e il crimine, Vienna.
UNODCCP (Ufficio delle Nazioni Unite per il controllo della droga e la prevenzione della criminalità) (2000), Demand reduction: a glossary of terms, Nazioni Unite: New York.
Vaglum, P. (1996), «Psychopathology and substance abuse: clinical Lessons from six Norwegian Studies», Psychiatric Fennica, n. 27, pagg. 55–67.
Van den Bosch, L. M., Verheul, R., Van den Brink, W. (2001), «Substance abuse in borderline personality disorder: clinical and etiological correlates», Journal of Personality Disorders, n. 15, pagg. 416–424.
Van Rooijen, M. (2001), «Zendingswerk: dubbele diagnose klinik», Psy, n. 5, pagg. 24–28.
Verheul, R. (2001), «Co-morbidity of personality disorders in individuals with substance use disorders», European Psychiatry, pag. 16, pagg. 274–282.
OMD (2003a), Drug routes from Central Asia to Europe (disponibile sul sito web dell’Organizzazione mondiale delle dogane, WCO).
OMD (2003b), An integrated international response to drug smuggling, OMD, Bruxelles.
OMD (2003c), World money laundering report, vol. 4, n. 10.
Weaver, T., Madden, P., Charles, V., et al. (2003), «Co-morbidity of substance misuse and mental illness in community mental health and substance misuse services», British Journal of Psychiatry, n. 183, pagg. 304–312.
OMS (1995), Lexicon of alcohol and drug terms, Organizzazione mondiale della sanità, Ginevra.
Wiessing, L., Kretzschmar, M. (2003), «Can HIV epidemics among IDUs ‘trigger’ a generalised epidemic?», International Journal of Drugs Policy, n. 14, pagg. 99–102.
Williams, H., O’Connor, J.J., Kinsella, A. (1990), «Depressive symptoms in opiate addicts on methadone maintenance», Irish Journal of Psychological Medicine, n. 7, pagg. 45–46.
Wolf, J., Mensink, C., Van der Lubbe, P. (2002), Casemanagement voor langdurig verslaafden met meervoudige problemen: een systematisch overzicht van interventie en effect, Ontwikkelcentrum Sociaal Verslavingsbeleid, Utrecht.
Zuckerman, J. (2003), «The place of accelerated schedules for hepatitis A and hepatitis B vaccinations», Drugs, n. 63, pagg. 1779–1784.
Zurhold, H., Kreutzfeldt, N., Degkwitz, P., Verthein, U. (2001), Drogenkonsumräume. Gesundheitsförderung und Minderung öffentlicher Belastungen in europäischen Grossstädten, Lambertus, Friburgo.